Dr. Michael Nadeem Kandalaft, MD

Dr. Kandalaft practices at William P. Clements Jr. University Hospital in Dallas, Texas, part of The University of Texas System.

Dr. Kandalaft's NPI, 1912468984, was assigned on March 30, 2019. Dr. Kandalaft graduated from Texas Tech University Health Sciences Center School of Medicine in 2019. Dr. Kandalaft holds Texas license U1048.

Dr. Kandalaft's primary practice is William P. Clements Jr. University Hospital, at 6201 Harry Hines Blvd, Dallas, TX 75390 in Dallas County. The practice phone is (214) 633-5555.

Dr. Kandalaft's primary practice is William P. Clements Jr. University Hospital in Dallas, Texas, part of The University of Texas System. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Kandalaft to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kandalaft practices, 2 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Kandalaft's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Kandalaft is board certified in psychiatry by the American Board of Psychiatry and Neurology. Dr. Kandalaft is licensed in Texas.

CMS data shows 185 Medicare services from Dr. Kandalaft across 4 procedure codes in 2024, for 43 Medicare patients. Medicare paid $11,796 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 43 Medicare patients who saw Dr. Kandalaft in 2024. The largest group is under 65, with 15 patients. 75% of them have anxiety, and 75% have depression. 26% are also on Medicaid. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kandalaft's median patient age at 45, with 56% women.

In 2024, Dr. Kandalaft wrote 145 Medicare Part D claims for 38 patients. 94% of them were for generic drugs. CMS names the drug for 139 of them, across 7 drugs with 11 or more claims each, at $3,816 in total drug cost. In 2021, CMS named 25 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Kandalaft for performance year 2024, reported as part of a group. Dr. Kandalaft accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kandalaft as offering telehealth.

Dr. Kandalaft graduated from Texas Tech University Health Sciences Center School of Medicine in 2019.

Dr. Kandalaft is in network with 9 carriers, including United Healthcare, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.